Drug-eluting Beads

DEVICE2 trials

Sponsors

National Institutes of Health Clinical Center (CC), Beijing Tsinghua Chang Gung Hospital

Conditions

Colorectal NeoplasmsHepatocellular CarcinomaMelanomaNeoplasm Metastases

Phase 1

Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads

TerminatedNCT01336985

National Institutes of Health Clinical Center (CC)Colorectal Neoplasms, Melanoma, Neoplasm Metastases

Start: 2011-03-28End: 2011-03-28Updated: 2019-12-17

Unknown Phase

Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria;

Beijing Tsinghua Chang Gung HospitalHepatocellular Carcinoma

Start: 2020-03-18End: 2025-12-31Target: 226Updated: 2021-02-04